Selected Publications from over 40

Latest Publications

  • G. Mittal, H. Carswell, R. Brett, S. Currie and M.N.V. Ravi Kumar, Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer’s pathology. Journal of Controlled Release 150 (2011) 220–228.
  • V. Bhardwaj, J. A. Plumb, J. Cassidy, M. N. V. Ravi Kumar, Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer, Cancer Nano 1 (2010) 29-34.
  • G. Sharma, K. Wilson, C.F. van der Walle, N. Sattar, J.R. Petrie and M.N.V. Ravi Kumar, Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats, European J Pharm Biopharm 76 (2010) 159–169.
  • D. D. Ankola, A. Battisti, R. Solaro and M. N. V. Ravi Kumar, Nanoparticles made of multiblock copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A. J Royal Soc Interface 7(2010) 475-481.
  • D. D. Ankola, E. W. Durbin, G. A. Buxton, J. Schäfer, U. Bakowsky and M. N. V. Ravi Kumar, Preparation, characterization and in silico modeling of biodegradable nanoparticles containing Cyclosporine A and Coenzyme Q10, Nanotechnology  21 (2010) 065104.
  • V Bhardwaj, D D Ankola, S C Gupta, M Schneider, C.-M Lehr, M. N. V. Ravi Kumar. PLGA nanoparticles stabilized with cationic surfactant: Safety studies and application in oral delivery of paclitaxel to treat chemical induced breast cancer in rat. Pharmaceutical Research 26 (2009) 2495-2503.
  • D. D. Ankola, M. N. V. Ravi Kumar, F Chiellini and R Solaro Multiblock Copolymers of Lactic Acid and Ethylene Glycol Containing Periodic Side–Chain Carboxyl Groups: Synthesis, Characterization and Nanoparticle Preparation. Macromolecules 42 (2009) 7388-7395.
  • D. Venkat Ratnam, G. Chandraiah, A. K. Meena, P. Rama Rao, M. N. V. Ravi Kumar. The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats. Journal of Nanoscience and Nanotechnology 9 (2009) 6741-6746.
  • G. Mittal and M. N. V. Ravi Kumar, Impact of polymeric nanoparticles on oral pharmacokinetics: A dose-dependent case study with estradiol. Journal of Pharmaceutical Sciences 98 (2009) 3730-3734.
  • J. Shaikh, D. D. Ankola, V. Beniwal, D. Singh, and M. N. V. Ravi Kumar. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9 fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences 37 (2009) 223-230.
  • D. D. Ankola, E. W. Durbin, G. A. Buxton, J. Schäfer, U. Bakowsky and M. N. V. Ravi Kumar, Preparation, characterization and in silico modeling of biodegradable nanoparticles containing Cyclosporine A and Coenzyme Q10, Nanotechnology (In Press)
  • V Bhardwaj, D D Ankola, S C Gupta, M Schneider, C.-M Lehr, M. N. V. Ravi Kumar. PLGA nanoparticles stabilized with cationic surfactant: Safety studies and application in oral delivery of paclitaxel to treat chemical induced breast cancer in rat. Pharmaceutical Research 26 (2009) 2495-2503.
  • D. D. Ankola, M. N. V. Ravi Kumar, F Chiellini and R Solaro Multiblock Copolymers of Lactic Acid and Ethylene Glycol Containing Periodic Side–Chain Carboxyl Groups: Synthesis, Characterization and Nanoparticle Preparation. Macromolecules 42 (2009) 7388-7395.
  • D. Venkat Ratnam, G. Chandraiah, A. K. Meena, P. Rama Rao, M. N. V. Ravi Kumar. The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats. Journal of Nanoscience and Nanotechnology 9 (2009) 6741-6746
  • G. Mittal and M. N. V. Ravi Kumar, Impact of polymeric nanoparticles on oral pharmacokinetics: A dose-dependent case study with estradiol. Journal of Pharmaceutical Sciences 98 (2009) 3730-3734.
  • J. Shaikh, D. D. Ankola, V. Beniwal, D. Singh, and M. N. V. Ravi Kumar. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9 fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences 37 (2009) 223-230.
  • J. L. Italia, M. M. Yahya, D. Singh, and M. N. V. Ravi Kumar, Biodegradable nanoparticles improve oral bioavailability of Amphotericin B and shows reduced nephrotoxicity against intravenous Fungizone®, Pharmaceutical Research 26 (2009) 1324-1331.
  • J. L. Italia, D. Singh and M. N. V. Ravi Kumar, High-performance liquid chromatographic analysis of amphotericin B in rat plasma using -naphthol as an internal standard. Analytica Chimica Acta 634 (2009) 110-114.
  • D. Kalaria, G. Sharma, V. Beniwal and M. N. V. Ravi Kumar, Design of biodegradable nanoparticles for oral delivery of Doxorubicin: In vivo pharmacokinetics and toxicity studies in rats, Pharmaceutical Research 26 (2009) 492-501
  • G. Mittal, G. Chandraiah, P. Ramarao and M.N.V. Ravi Kumar. Pharmacodynamic evaluation of oral estradiol nanoparticles in estrogen deficient (ovariectomized) high-fat diet induced hyperlipidemic female rat model. Pharmaceutical Research 26 (2009) 218-223.

We make news

One of the recent research articles was covered in Nature News...

Read more...

Training programs

Two Days Conference on Nanotechnology in Advanced Drug Delivery...

Read more...